Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioavailability of Antioxidant Compounds and Effect on Markers of Inflammation by Ingestion of a Hibiscus Sabdariffa Beverage With Glicemic and Insulinemic Response

NCT05774613 is registered in ClinicalTrials.gov with Instituto Tecnológico y de Estudios Superiores de Occidente as lead sponsor.

NCT NCT05774613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05774613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioavailability of Antioxidant Compounds and Effect on Markers of Inflammation by Ingestion of a Hibiscus Sabdariffa Beverage With Glicemic and Insulinemic Response
Lead sponsor
Instituto Tecnológico y de Estudios Superiores de Occidente
Phase
Not applicable
Overall status
Unknown status
Start date
June 12, 2021
Completion date
June 30, 2023
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperglycemia, postprandial, hyperinsulinism, markers of inflammation